GlassScriptPhysician profile
Jason A Nydick
NPI 1417108374
$346,003.65
in general payments reported to CMS, 2019-2025
20 companies · $64K in 2025
The $64K reported for 2025 was more than what 96% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57K · 2020: $12K · 2021: $25K · 2022: $38K · 2023: $54K · 2024: $98K · 2025: $64K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $108K · Consulting Fee: $64K · Travel and Lodging: $23K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $10K · Food and Beverage: $6,435 · Honoraria: $3,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $107,680.76 |
| Consulting Fee | $64,038.50 |
| Travel and Lodging | $23,454.07 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $10,406.25 |
| Food and Beverage | $6,435.17 |
| Honoraria | $3,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trimed, INC. | $236,587.30 | 2019-2025 | |
| Axogen | $49,633.64 | 2019-2025 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Connector |
| Endo Pharmaceuticals INC. | $20,084.13 | 2019-2024 | Xiaflex |
| Endo USA, INC. | $12,927.60 | 2024-2025 | Xiaflex |
| Medical Device Business Services, INC. | $12,428.07 | 2019 | |
| Linvatec Corporation | $11,207.31 | 2019-2022 | |
| Checkpoint Surgical, INC | $1,087.97 | 2019-2021 | |
| Stryker Corporation | $907.36 | 2019-2024 | Aequalis Perform, Aequalis Perform Reversed |
| Trice Medical, INC. | $270.56 | 2022-2024 | |
| Integra Lifesciences Corporation | $207.71 | 2019-2023 | Tenoglide |
| Zimmer Biomet Holdings, INC. | $190.64 | 2024 | Affixus |
| Medartis INC. | $134.38 | 2023 | Aptus |
| Horizon Therapeutics Plc | $108.60 | 2019 | |
| Coastal Medical Technologies LLC | $72.66 | 2025 | |
| Smith+Nephew, INC. | $71.29 | 2020-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mvp Orthopedics INC | $27.36 | 2022 | |
| Biocircuit Technologies INC | $19.32 | 2025 | Nerve Tape |
| Bioventus LLC | $19.02 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $18.73 | 2025 | Exparel |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Nydick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.